ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

AtriCure, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 27, 2026

$55.53−0.54 (-0.96%)

Close on Oct 19, 2026

Market cap: $2.71B
P/E (TTM): 264.4
Dividend yield: –

AtriCure, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	535	465	399	330	274	207	231	202	175	155	130	107	82	70	64	59	55
Cost of Revenue	134	118	99	84	68	57	60	55	49	44	37	32	22	20	17	14	13
Gross Profit	401	348	300	246	206	149	170	147	126	111	93	76	60	50	47	45	42
Research & Development	99	96	74	57	49	43	41	35	34	36	26	19	13	12	12	12	11
Selling, General & Admin	311	291	253	231	205	151	167	130	117	106	94	74	57	45	40	37	35
Advertising Expenses	2.23	2.82	1.70	1.23	0.91	0.66	0.64	–	–	–	–	–	–	–	–	–	–
Operating Expenses	410	388	327	289	151	194	203	164	151	142	120	92	70	57	52	49	57
Operating Income	-9.45	-40	-27	-43	55	-44	-33	-17	-25	-31	-27	-16	-11	-7.20	-4.73	-3.19	-16
Interest Expense	5.88	6.41	6.93	4.99	4.92	4.89	4.11	4.61	2.26	1.80	0.29	0.31	0.57	0.80	0.81	0.86	0.81
Interest & Investment Income	4.48	4.43	3.79	1.99	0.47	1.10	2.40	1.01	0.23	0.23	0.19	0.10	0.02	0.01	0.02	0.02	0.05
Other Non-Operating Income	0.68	-0.33	-0.03	-0.54	-0.37	-0.02	-0.16	-0.18	0.14	-0.59	-0.35	0.39	0.00	0.51	0.10	0.26	-0.28
Asset Impairment Charges	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	6.81
Gain (Loss) on Investments	0	0	0	0	0	0	0	0	0	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	-0.28	-0.60	-0.32	-0.34	-0.43	-0.28	-0.12	0.01	-0.04	-0.06	0.04	-0.01
Pretax Income	-10	-44	-30	-46	50	-48	-35	-21	-27	-33	-27	-16	-11	-7.48	-5.43	-3.77	-17
Income Tax Expense	1.29	1.02	0.59	0.27	0.19	0.11	0.20	0.23	0.01	0.04	0.04	0.03	0.02	0.05	0.03	0.02	-0.06
Net Income	-11	-45	-30	-46	50	-48	-35	-21	-27	-33	-27	-16	-11	-7.53	-5.46	-3.79	-16
EPS (Basic)(per share)	-0.24	-0.95	-0.66	-1.02	1.11	-1.14	-0.94	-0.62	-0.83	-1.05	-0.97	-0.61	-0.56	-0.47	-0.35	-0.25	-1.13
EPS (Diluted)(per share)	-0.24	-0.95	-0.66	-1.02	1.09	-1.14	-0.94	-0.62	-0.83	-1.05	-0.97	-0.61	-0.56	-0.47	-0.35	-0.25	-1.13
Shares Outstanding (Basic, Weighted)(shares)	48	47	46	46	45	42	38	34	32	32	28	26	20	16	16	15	–
Shares Outstanding (Diluted, Weighted)(shares)	48	47	46	46	46	42	38	34	32	32	28	26	20	16	16	15	–
Net Interest Income	–	–	–	–	–	–	–	3.13	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 76.3%
Operating margin: 2.3%
Net margin: 1.9%
Return on equity, FY2025: -2.4%

Financial strength

Current ratio: 4.22
Debt to equity: 0.12
Debt to assets: 9.0%
Cash to current liabilities: 204.8%

Valuation

P/E ratio: 264.4
Price to sales: 4.76
Price to book: 5.25
Dividend yield: –